Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Specialized palliative care in patients with haematological malignancies receiving chimeric antigen receptor T-cell therapy.
Eichenauer DA, Heger JM, Kruschel I, Kutsch N, Gödel P, Garcia Borrega J, Schnetzke U, Böll B, Neumann MA, Gebel C, Pralong A, Borchmann P, Voltz R, Wedding U, Simon ST. Eichenauer DA, et al. Among authors: heger jm. Br J Haematol. 2024 Mar 24. doi: 10.1111/bjh.19434. Online ahead of print. Br J Haematol. 2024. PMID: 38522848 No abstract available.
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i).
Gillessen S, Hüttmann A, Vucinic V, Müller H, Plütschow A, Viardot A, Topp MS, Kobe C, Böll B, Eichenauer DA, Sasse S, Haverkamp H, Schmitz C, Borchmann S, Bröckelmann PJ, Heger JM, Fuchs M, Engert A, Borchmann P, von Tresckow B. Gillessen S, et al. Among authors: heger jm. Br J Haematol. 2022 Feb;196(3):606-616. doi: 10.1111/bjh.17878. Epub 2021 Nov 14. Br J Haematol. 2022. PMID: 34775591 Clinical Trial.
Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high-grade B-cell lymphoma.
Graef CM, Gödel P, Falderbaum P, Balke-Want H, Simon F, Sieg N, Naendrup JH, Neumann MA, Gillessen S, Bröckelmann PJ, Eichenauer DA, Borchmann P, von Tresckow B, Heger JM. Graef CM, et al. Among authors: heger jm. Eur J Haematol. 2022 May;108(5):403-412. doi: 10.1111/ejh.13747. Epub 2022 Feb 2. Eur J Haematol. 2022. PMID: 35090068
JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).
Gillessen S, Pluetschow A, Vucinic V, Ostermann H, Kobe C, Bröckelmann PJ, Böll B, Eichenauer DA, Heger JM, Borchmann S, Fuchs M, Borchmann P, Engert A, von Tresckow B. Gillessen S, et al. Among authors: heger jm. Eur J Haematol. 2022 Dec;109(6):728-735. doi: 10.1111/ejh.13859. Epub 2022 Oct 3. Eur J Haematol. 2022. PMID: 36056778 Clinical Trial.
Treatment patterns and disease course of previously untreated Primary Central Nervous System Lymphoma: Feasibility of MTX-based regimens in clinical routine.
Sieg N, Naendrup JH, Gödel P, Balke-Want H, Simon F, Deckert M, Gillessen S, Kreissl S, Bröckelmann PJ, Borchmann P, von Tresckow B, Heger JM. Sieg N, et al. Among authors: heger jm. Eur J Haematol. 2021 Aug;107(2):202-210. doi: 10.1111/ejh.13639. Epub 2021 May 26. Eur J Haematol. 2021. PMID: 33960535
Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis.
Garcia Borrega J, Böll B, Kochanek M, Naendrup JH, Simon F, Sieg N, Hallek M, Borchmann P, Holtick U, Shimabukuro-Vornhagen A, Eichenauer DA, Heger JM. Garcia Borrega J, et al. Among authors: heger jm. Ann Hematol. 2023 Jan;102(1):191-197. doi: 10.1007/s00277-022-05028-x. Epub 2022 Nov 17. Ann Hematol. 2023. PMID: 36394583 Free PMC article.
Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy.
Voltin CA, Gödel P, Beckmann L, Heger JM, Kobe C, Kutsch N, Borchmann P, Dietlein M, Herrmann K, Stelljes M, Rahbar K, Lenz G, Reinhardt HC, Teichert M, Noppeney R, Albring JC, Seifert R, von Tresckow B, Flossdorf S, Hanoun C. Voltin CA, et al. Among authors: heger jm. Hemasphere. 2023 Jan 6;7(1):e817. doi: 10.1097/HS9.0000000000000817. eCollection 2023 Jan. Hemasphere. 2023. PMID: 36698613 Free PMC article.
Noninvasive minimal residual disease assessment in relapsed/refractory large B-cell lymphoma using digital droplet PCR.
Heger JM, d'Hargues Y, Kleinert F, Mattlener J, Weiss J, Franzen F, Becker C, Becker K, Gödel P, Schmiel M, Meinel J, Flümann R, Simon F, Reinhardt HC, Borchmann P, Borchmann S, Balke-Want H, Knittel G, von Tresckow B. Heger JM, et al. Eur J Haematol. 2024 Jun;112(6):957-963. doi: 10.1111/ejh.14191. Epub 2024 Feb 18. Eur J Haematol. 2024. PMID: 38369814
23 results